{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T12:18:15Z","timestamp":1775909895386,"version":"3.50.1"},"reference-count":43,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>IMPORTANCE:<\/jats:title>\n            <jats:p>Ventilator-associated pneumonia (VAP) frequently occurs in patients with cardiac arrest. Diagnosis of VAP after cardiac arrest remains challenging, while the use of current biomarkers such as C-reactive protein (CRP) or procalcitonin (PCT) is debated.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>OBJECTIVES:<\/jats:title>\n            <jats:p>To evaluate biomarkers\u2019 impact in helping VAP diagnosis after cardiac arrest.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>DESIGN, SETTING, AND PARTICIPANTS:<\/jats:title>\n            <jats:p>This is a prospective ancillary study of the randomized, multicenter, double-blind placebo-controlled ANtibiotherapy during Therapeutic HypothermiA to pRevenT Infectious Complications (ANTHARTIC) trial evaluating the impact of antibiotic prophylaxis to prevent VAP in out-of-hospital patients with cardiac arrest secondary to shockable rhythm and treated with therapeutic hypothermia. An adjudication committee blindly evaluated VAP according to predefined clinical, radiologic, and microbiological criteria. All patients with available biomarker(s), sample(s), and consent approval were included.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>MAIN OUTCOMES AND MEASURES:<\/jats:title>\n            <jats:p>The main endpoint was to evaluate the ability of biomarkers to correctly diagnose and predict VAP within 48 hours after sampling. The secondary endpoint was to study the combination of two biomarkers in discriminating VAP. Blood samples were collected at baseline on day 3. Routine and exploratory panel of inflammatory biomarkers measurements were blindly performed. Analyses were adjusted on the randomization group.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>RESULTS:<\/jats:title>\n            <jats:p>Among 161 patients of the ANTHARTIC trial with available biological sample(s), patients with VAP (<jats:italic toggle=\"yes\">n<\/jats:italic> = 33) had higher body mass index and Acute Physiology and Chronic Health Evaluation II score, more unwitnessed cardiac arrest, more catecholamines, and experienced more prolonged therapeutic hypothermia duration than patients without VAP (<jats:italic toggle=\"yes\">n<\/jats:italic> = 121). In univariate analyses, biomarkers significantly associated with VAP and showing an area under the curve (AUC) greater than 0.70 were CRP (AUC = 0.76), interleukin (IL) 17A and 17C (IL17C) (0.74), macrophage colony-stimulating factor 1 (0.73), PCT (0.72), and vascular endothelial growth factor A (VEGF-A) (0.71). Multivariate analysis combining novel biomarkers revealed several pairs with <jats:italic toggle=\"yes\">p<\/jats:italic> value of less than 0.001 and odds ratio greater than 1: VEGF-A + IL12 subunit beta (IL12B), Fms-related tyrosine kinase 3 ligands (Flt3L) + C\u2013C chemokine 20 (CCL20), Flt3L + IL17A, Flt3L + IL6, STAM-binding protein (STAMBP) + CCL20, STAMBP + IL6, CCL20\u2009+\u20094EBP1, CCL20 + caspase-8 (CASP8), IL6\u2009+\u20094EBP1, and IL6 + CASP8. Best AUCs were observed for CRP + IL6 (0.79), CRP + CCL20 (0.78), CRP + IL17A, and CRP + IL17C.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSIONS AND RELEVANCE:<\/jats:title>\n            <jats:p>Our exploratory study shows that specific biomarkers, especially CRP combined with IL6, could help to better diagnose or predict early VAP occurrence in cardiac arrest patients.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/cce.0000000000001104","type":"journal-article","created":{"date-parts":[[2024,7,3]],"date-time":"2024-07-03T14:06:47Z","timestamp":1720015607000},"page":"e1104","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Can Biomarkers Correctly Predict Ventilator-associated Pneumonia in Patients Treated With Targeted Temperature Management After Cardiac Arrest? An Exploratory Study of the Multicenter Randomized Antibiotic (ANTHARTIC) Study"],"prefix":"10.1097","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1652-1540","authenticated-orcid":false,"given":"Nicolas","family":"Deye","sequence":"first","affiliation":[{"name":"Medical ICU, Lariboisiere University Hospital, Inserm UMR-S 942, APHP, Paris, France."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amelie","family":"Le Gouge","sequence":"additional","affiliation":[{"name":"Inserm CIC 1415, CHU de Tours, Tours, France."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno","family":"Fran\u00e7ois","sequence":"additional","affiliation":[{"name":"R\u00e9animation Polyvalente, INSERM CIC 1435 and UMR 1092, CHU Limoges, Limoges, France."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camille","family":"Chenevier-Gobeaux","sequence":"additional","affiliation":[{"name":"Biochemical Laboratory, Cochin University Hospital, APHP, Paris, France."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Daix","sequence":"additional","affiliation":[{"name":"R\u00e9animation Polyvalente, INSERM CIC 1435 and UMR 1092, CHU Limoges, Limoges, France."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hamid","family":"Merdji","sequence":"additional","affiliation":[{"name":"Service de M\u00e9decine Intensive\u2013R\u00e9animation, Nouvel H\u00f4pital Civil, H\u00f4pitaux Universitaires de Strasbourg, INSERM UMR 1260, Regenerative NanoMedicine, FMTS, Strasbourg, France."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alain","family":"Cariou","sequence":"additional","affiliation":[{"name":"Medical ICU, Cochin University Hospital, AP-HP Centre Universit\u00e9 Paris Cit\u00e9, Paris, France."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre-Fran\u00e7ois","family":"Dequin","sequence":"additional","affiliation":[{"name":"INSERM UMR 1100 and M\u00e9decine Intensive\u2013R\u00e9animation, Tours, France."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christophe","family":"Guitton","sequence":"additional","affiliation":[{"name":"Medecine Intensive R\u00e9animation, Center Hospitalier Universitaire, Nantes, France."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno","family":"M\u00e9garbane","sequence":"additional","affiliation":[{"name":"Department of Medical and Toxicological Critical Care, Paris Cit\u00e9 University, Lariboisiere University Hospital, Inserm UMR-S 1144, Paris, France."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacques","family":"Callebert","sequence":"additional","affiliation":[{"name":"Biochemical Laboratory, Lariboisiere University Hospital, Inserm UMR-S 1144, Paris, France."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno","family":"Giraudeau","sequence":"additional","affiliation":[{"name":"Inserm CIC 1415, CHU de Tours, Tours, France."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandre","family":"Mebazaa","sequence":"additional","affiliation":[{"name":"Universit\u00e9 de Paris, Inserm UMR-S 942 MASCOT, Paris, France"},{"name":"Department of Anaesthesiology and Intensive Care, Lariboisi\u00e8re University Hospital, APHP, Paris, France."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas","family":"Vodovar","sequence":"additional","affiliation":[{"name":"Universit\u00e9 de Paris, Inserm UMR-S 942 MASCOT, Paris, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"for the Clinical Research in Intensive Care and Sepsis-TRIal Group for Global Evaluation and Research in SEPsis (TRIGGERSEP) Network and the ANtibiotherapy during Therapeutic HypothermiA to pRevenT Infectious Complications (ANTHARTIC) Study Group","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2024,7,1]]},"reference":[{"key":"R1-20240806","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1164\/rccm.201102-0331OC","article-title":"Early-onset pneumonia after cardiac arrest: Characteristics, risk factors and influence on prognosis.","volume":"184","author":"Perbet","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"R2-20240806","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.4187\/respcare.02307","article-title":"Predictors and outcome of early-onset pneumonia after out-of-hospital cardiac arrest.","volume":"58","author":"Pabst","year":"2013","journal-title":"Respir Care"},{"key":"R3-20240806","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/CCM.0b013e3181fa4301","article-title":"Adverse events and their relation to mortality in out-of-hospital cardiac arrest patients treated with therapeutic hypothermia.","volume":"39","author":"Nielsen","year":"2011","journal-title":"Crit Care Med"},{"key":"R4-20240806","doi-asserted-by":"crossref","first-page":"1700582","DOI":"10.1183\/13993003.00582-2017","article-title":"International ERS\/ESICM\/ESCMID\/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia. TASK FORCE REPORT ERS\/ESICM\/ESCMID\/ALAT GUIDELINES.","volume":"50","author":"Torres","year":"2017","journal-title":"Eur Respir J"},{"key":"R5-20240806","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0300-9572(03)00164-3","article-title":"Procalcitonin serum levels after out-of-hospital cardiac arrest.","volume":"59","author":"Fries","year":"2003","journal-title":"Resuscitation"},{"key":"R6-20240806","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1007\/s12028-009-9318-5","article-title":"Comparison of the predictability of neurological outcome by serum procalcitonin and glial fibrillary acidic protein in postcardiac-arrest patients.","volume":"12","author":"Hayashida","year":"2010","journal-title":"Neurocrit Care"},{"key":"R7-20240806","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1111\/j.1365-2362.2010.02259.x","article-title":"Serum procalcitonin, C-reactive protein and white blood cell levels following hypothermia after cardiac arrest: A retrospective cohort study.","volume":"40","author":"Schuetz","year":"2010","journal-title":"Eur J Clin Invest"},{"key":"R8-20240806","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.resuscitation.2013.01.004","article-title":"Procalcitonin after cardiac arrest\u2014an indicator of severity of illness, ischemia-reperfusion injury and outcome.","volume":"84","author":"Annborn","year":"2013","journal-title":"Resuscitation"},{"key":"R9-20240806","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.resuscitation.2013.01.029","article-title":"Serum procalcitonin as a marker of post-cardiac arrest syndrome and long-term neurological recovery, but not of early-onset infections, in comatose post-anoxic patients treated with therapeutic hypothermia.","volume":"84","author":"Engel","year":"2013","journal-title":"Resuscitation"},{"key":"R10-20240806","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0300-9572(02)00008-4","article-title":"Elevations in procalcitonin but not C-reactive protein are associated with pneumonia after cardiopulmonary resuscitation.","volume":"53","author":"Oppert","year":"2002","journal-title":"Resuscitation"},{"key":"R11-20240806","first-page":"e4","article-title":"Copeptin, procalcitonin and routine inflammatory markers-predictors of infection after stroke.","volume":"12","author":"Fluri","year":"8309","journal-title":"PLoS One"},{"key":"R12-20240806","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1097\/01.ccx.0000126090.06275.fe","article-title":"Postresuscitation disease after cardiac arrest: A sepsis-like syndrome?","volume":"10","author":"Adrie","year":"2004","journal-title":"Curr Opin Crit Care"},{"key":"R13-20240806","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1186\/cc8155","article-title":"Clinical review: The role of biomarkers in the diagnosis and management of community acquired pneumonia.","volume":"14","author":"Christ-Crain","year":"2010","journal-title":"Crit Care"},{"key":"R14-20240806","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1164\/rccm.200506-888OC","article-title":"Preinfection systemic inflammatory markers and risk of hospitalization due to pneumonia.","volume":"172","author":"Yende","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"R15-20240806","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s10096-006-0168-1","article-title":"Evaluation of serum C-reactive protein, procalcitonin, tumor necrosis factor alpha, and interleukin-10 levels as diagnostic and prognostic parameters in patients with community-acquired sepsis, severe sepsis, and septic shock.","volume":"25","author":"Heper","year":"2006","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"R16-20240806","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.3390\/ijms20082004","article-title":"Biomarkers in pneumonia\u2014beyond procalcitonin.","volume":"20","author":"Karakioulaki","year":"2019","journal-title":"Int J Mol Sci"},{"key":"R17-20240806","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1002\/ppul.26023","article-title":"Pilot study of inflammatory biomarkers in matched induced sputum and bronchoalveolar lavage of 2-year-olds with cystic fibrosis.","volume":"57","author":"Giacalone","year":"2022","journal-title":"Pediatr Pulmonol"},{"key":"R18-20240806","doi-asserted-by":"crossref","first-page":"117788","DOI":"10.1016\/j.lfs.2020.117788","article-title":"The role of biomarkers in diagnosis of COVID-19\u2014a systematic review.","volume":"254","author":"Kermalia","year":"2020","journal-title":"Life Sci"},{"key":"R19-20240806","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1056\/NEJMoa1812379","article-title":"Prevention of early ventilator-associated pneumonia after cardiac arrest.","volume":"381","author":"Fran\u00e7ois","year":"2019","journal-title":"N Engl J Med"},{"key":"R20-20240806","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.pbb.2010.12.008","article-title":"Evidence for a key role of the peripheral kynurenine pathway in the modulation of anxiety- and depression-like behaviours in mice: Focus on individual differences.","volume":"98","author":"Laugeray","year":"2011","journal-title":"Pharmacol Biochem Behav"},{"key":"R22-20240806","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1097\/CCM.0b013e3182120b56","article-title":"Infectious complications in out-of-hospital cardiac arrest patients in the therapeutic hypothermia era.","volume":"39","author":"Mongardon","year":"2011","journal-title":"Crit Care Med"},{"key":"R23-20240806","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1111\/j.1399-6576.2009.02021.x","article-title":"Outcome, timing and adverse events in therapeutic hypothermia after out-of-hospital cardiac arrest.","volume":"53","author":"Nielsen","year":"2009","journal-title":"Acta Anaesthesiol Scand"},{"key":"R24-20240806","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1111\/aas.14063","article-title":"Increased risk of ventilator-associated pneumonia in patients after cardiac arrest treated with mild therapeutic hypothermia.","volume":"66","author":"Hasslacher","year":"2022","journal-title":"Acta Anaesthesiol Scand"},{"key":"R25-20240806","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1007\/s00134-009-1681-3","article-title":"Value of procalcitonin for diagnosis of early onset pneumonia in hypothermia-treated cardiac arrest patients.","volume":"36","author":"Mongardon","year":"2010","journal-title":"Intensive Care Med"},{"key":"R26-20240806","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1097\/CCM.0b013e31820a942c","article-title":"Diagnostic use of serum procalcitonin levels in pulmonary aspiration syndromes.","volume":"39","author":"El-Sohl","year":"2011","journal-title":"Crit Care Med"},{"key":"R27-20240806","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.resuscitation.2016.12.008","article-title":"Infectious complications after out-of-hospital cardiac arrest\u2014a comparison between two target temperatures.","volume":"113","author":"Dankiewicz","year":"2017","journal-title":"Resuscitation"},{"key":"R28-20240806","doi-asserted-by":"crossref","first-page":"4432","DOI":"10.4049\/jimmunol.170.9.4432","article-title":"Cutting edge: Roles of Toll-like receptor 4 and IL-23 in IL-17 expression in response to Klebsiella pneumoniae infection.","volume":"170","author":"Happel","year":"2003","journal-title":"J Immunol"},{"key":"R29-20240806","doi-asserted-by":"crossref","first-page":"e109","DOI":"10.1038\/cti.2016.65","article-title":"Non-small cell lung cancer is characterised by a distinct inflammatory signature in serum compared with chronic obstructive pulmonary disease.","volume":"5","author":"Eide","year":"2016","journal-title":"Clin Transl Immunology"},{"key":"R30-20240806","doi-asserted-by":"crossref","first-page":"e12238","DOI":"10.1002\/clt2.12238","article-title":"Obese asthma phenotypes display distinct plasma biomarker profiles.","volume":"13","author":"Bj\u00f6rkander","year":"2023","journal-title":"Clin Transl Allergy"},{"key":"R31-20240806","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1002\/alr.22977","article-title":"Steroid affected cytokines in aspirin-exacerbated respiratory disease.","volume":"12","author":"Hui Tan","year":"2022","journal-title":"Int Forum Allergy Rhinol"},{"key":"R32-20240806","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.resuscitation.2019.02.041","article-title":"Procalcitonin as a prognostic marker for outcomes in post-cardiac arrest patients: A systematic review and meta-analysis.","volume":"138","author":"Shin","year":"2019","journal-title":"Resuscitation"},{"key":"R33-20240806","doi-asserted-by":"crossref","first-page":"104370","DOI":"10.1016\/j.jcv.2020.104370","article-title":"Prognostic value of interleukin-6, C-reactive protein, and procalcitonin in patients with COVID-19.","volume":"127","author":"Liu","year":"2020","journal-title":"J Clin Virol"},{"key":"R34-20240806","doi-asserted-by":"crossref","first-page":"108614","DOI":"10.1016\/j.clim.2020.108614","article-title":"Laboratory biomarkers associated with COVID-19 severity and management.","volume":"221","author":"Keddie","year":"2020","journal-title":"Clin Immunol"},{"key":"R35-20240806","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1161\/CIRCULATIONAHA.120.053318","article-title":"Treatment effects of interleukin-6 receptor antibodies for modulating the systemic inflammatory response after out-of-hospital cardiac arrest (the IMICA Trial): A double-blinded, placebo-controlled, single-center, randomized, clinical trial.","volume":"143","author":"Meyer","year":"2021","journal-title":"Circulation"},{"key":"R36-20240806","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s13054-022-04297-2","article-title":"Efficacy and safety of corticosteroids in cardiac arrest: A systematic review, meta-analysis and trial sequential analysis of randomized control trials.","volume":"27","author":"Penn","year":"2023","journal-title":"Crit Care"},{"key":"R37-20240806","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.resuscitation.2021.02.012","article-title":"European Resuscitation Council and European Society of Intensive Care Medicine Guidelines 2021: Post-resuscitation care.","volume":"161","author":"Nolan","year":"2021","journal-title":"Resuscitation"},{"key":"R38-20240806","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1056\/NEJMoa2100591","article-title":"Hypothermia versus normothermia after out-of-hospital cardiac arrest.","volume":"384","author":"Dankiewicz","year":"2021","journal-title":"N Engl J Med"},{"key":"R39-20240806","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1007\/s00134-021-06505-z","article-title":"Targeted temperature management following out-of-hospital cardiac arrest: A systematic review and network meta-analysis of temperature targets.","volume":"47","author":"Fernando","year":"2021","journal-title":"Intensive Care Med"},{"key":"R40-20240806","doi-asserted-by":"crossref","first-page":"109928","DOI":"10.1016\/j.resuscitation.2023.109928","article-title":"Temperature control after adult cardiac arrest: An updated systematic review and meta-analysis.","volume":"191","author":"Granfeldt","year":"2023","journal-title":"Resuscitation"},{"key":"R41-20240806","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1001\/jamaneurol.2023.4820","article-title":"Hypothermia vs normothermia in patients with cardiac arrest and nonshockable rhythm: A meta-analysis.","volume":"81","author":"Taccone","year":"2024","journal-title":"JAMA Neurol"},{"key":"R42-20240806","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/EVIDoa2200137","article-title":"Hypothermic versus normothermic temperature control after cardiac arrest.","volume":"1","author":"Holgersson","year":"2022","journal-title":"NEJM evidence"},{"key":"R43-20240806","doi-asserted-by":"crossref","first-page":"e48","DOI":"10.1161\/CIR.0000000000001095","article-title":"2022 International consensus on cardiopulmonary resuscitation and emergency cardiovascular care science with treatment recommendations: Summary from the basic life support; advanced life support; pediatric life support; neonatal life support; education, implementation, and teams; and first aid task forces.","volume":"146","author":"Wyckoff","year":"2022","journal-title":"Circulation"},{"key":"R44-20240806","first-page":"CD004128","article-title":"Hypothermia for neuroprotection in adults after cardiac arrest (review).","volume":"2023","author":"Arrich","year":"2023","journal-title":"Cochrane Database Systemat Reviews"}],"container-title":["Critical Care Explorations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CCE.0000000000001104","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T22:11:12Z","timestamp":1722982272000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CCE.0000000000001104"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,1]]},"references-count":43,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/cce.0000000000001104","relation":{},"ISSN":["2639-8028"],"issn-type":[{"value":"2639-8028","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,1]]}}}